ARCHIVES

Erbitux Plus Chemo Effective For NSCLC; Carboplatin Prevents Testicular Recurrence

This article is from The Cancer Letter archive.

Vol. 31 No. 7 | July 25, 2008

Download PDF Visit The Full Archive

Related Articles

Bristol-Myers, USDA Agreement n Yew Harvest Is Near; Agencies Plan Public Briefings On Taxol

June 14, 1991

Emil Frei, Pioneer of Combination Chemotherapy, Dies at 89

May 10, 2013

Lymphatic Mapping Techniques Can Outperform “Watch-and-Wait”

February 28, 2014

GM Corp, to Reimburse Marrow Transplants for Breast Cancer

March 15, 1996

States Sue Bristol-Myers Alleging Firm Took Illegal Actions To Block Taxol Competitors

June 7, 2002

Nobel Physicist Calls For Doubling Of Science Budget

January 11, 1991